Conference Objectives

PEIP is a forum targeted at family physicians, allied health care providers, residents, and students to learn, discuss, and share the latest studies on evidence-based medicine and new drug therapies in order to equip health care professionals with the best, unbiased information to provide better clinical experience and patient care. Our objectives are:

  • To raise awareness for the evidence-based discipline of practice and research in order to further educate family physicians and health providers on how they practice,
  • To present a continuing professional development (CPD) event focused on evidence-based medicine for ACFP members, CFPC members, and allied health care professionals,
  • To present a positive and well-received CPD event experience in order to build brand awareness and equity to continue the event on an annual basis.

Session Objectives

Session topics for the 2017 PEIP conference are tailored, primarily, from the evaluation feedback received from attendees of the 2016 conference. Topic suggestions are collated and chosen based on frequency of request; the topics represent common clinical scenarios where new information or an evidence-based review could potentially change practice.

Session Title During the session, the presenter(s) will: Presenter(s)
What’s New, What’s True, What’s Poo
  • Review recent research relevant to primary care and discuss whether its implications are practice changing or should be ignored.
Mike Allan
Mike Kolber
Tina Korownyk
Adrienne Lindblad
Who Gives a “CHEP” About Targets? A Hypertension Update
  • Review recent research relevant to the management of hypertension,
  • Discuss the recent updates to, and key features of, the CHEP guidelines,
  • Provide recommendations around targets (e.g. when to implement therapy and what BP targets should be used in what groups).
Raj Padwal
Diabetic Sugar Meds: The Unsweetened Evidence for Outcomes That Matter Most
  • Briefly review the clinically relevant patient orientated outcomes for commonly used glycemic medications (oral and insulins),
  • Explain the potential risks (and costs) of commonly used glycemic medications,
  • Provide insight into reasonable first, second, and third line agents for glycemic management.
James McCormack
Head’s Up: What’s the Latest on Concussion?
  • Review quick and easy tools for assessment in the office and on the sports field,
  • Inform about specialty clinics available for complicated cases,
  • Describe the common pitfalls for family physicians during the recovery period.
Dhiren Naidu
Don’t Let the Evidence on Depression Getcha Down
  • Review the evidence for pharmcologic treatment of depression, including potential benefits and harms,
  • Discuss the long-term outcomes of depression,
  • Describe the evidence for non-pharmacologic therapies for depression.
Adrienne Lindblad
Is it High-time for Medical Cannabis: Doobie-ous Evidence or Smokin’ Results?
  • Provide a review of the evidence of medical marijuana for conditions it is commonly used for (e.g. anorexia, spasticity, pain),
  • Review the evidence of the harms of medical marijuana use, including the risk of psychiatric disorders,
  • Briefly explain the relationship between medical marijuana (pills) and smoking marijuana, and the possible health benefits and risks of smoking marijuana.
Mike Allan
Opioids: The Cause of (and Solution to) All Things Pain
  • Discuss the efficacy and safety of opioid medications for use in chronic pain,
  • Review the likelihood of dependence and addiction to opioids and describe prevention strategies,
  • Describe the efficacy and safety of opioids in acute pain.
Jessica Kirkwood
Tina Korownyk
“About Face”: Marching to the Changing Tune of Medical Evidence
  • Review examples in which the medical community has seen a reversal in practice,
  • Develop tools to minimize the risk of falling into practice patterns that may be reversed in the near future.
Vinay Prasad
Interpreting Lab Tests: The Magic Nature of “Normal” Ranges and Repeat Testing
  • Review the most common sources of laboratory inaccuracies and how to spot them,
  • Discuss, in practical terms, the variability in commonly ordered lab tests.
James McCormack
Prevent, Treat, Repeat: Getting Ahead of Migraines
  • Review recent research relevant to primary care regarding diagnosis, treatment, and prevention of migraine headaches, including when to consider prophylaxis,
  • Review the role of imaging in migraine headache.
Jennifer Bestard
Do You See What I See (or Don’t)? Office-based Ophthalmology for the Primary Care Provider
  • Provide an evidence-based approach to the family physician’s approach to common office or emergency presentations of acute red eye, acute and chronic visual loss,
  • Provide evidence as to the benefit and harms of common ophthalmologic surgeries, including cataract and corrective surgeries,
  • Discuss the best evidence for the management of dry eyes, glaucoma, and allergic conjunctivitis.
Steve Roberts
Gas, Pain, No Bowel Control: “Irritable” is Not the Word for This BS
  • Discuss a practical office approach to the management of IBS, including antidepressants, PEG, FODMAPs,
  • Review work-up (e.g. is there a role for fecal calprotectic, CRP, and celiac in the work-up of IBS?),
  • Discuss if and how “red flags” are predictive of disease.
Mike Kolber
Trial and Tribulations: 2017 Update on the Pragmatic Trials Collaborative
  • Provide an update about recently completed Pragmatic Trials Collaborative (PTC) studies,
  • Advise attendees of current PTC studies and provide background of how research is rooted in family medicine and questions formulated by family physicians,
  • Advise attendees of the future of PTC.
Scott Garrison
Thyroid Nodules, Ultrasounds, Sailboats: Which One Does Not Belong?
  • Develop tools for the management of thyroid nodules in practice,
  • Solidify the appropriate use of ultrasounds in diagnosis and monitoring of thyroid nodules,
  • Reflect on the limitations of screening and diagnostic testing in work-up of thyroid nodules.
Jennifer Young
Understanding the Effects and Marketing of Cancer Drugs: A Glance Behind the FDA Curtain
  • Briefly explain how a cancer drug gets approved for use in the US and Canada,
  • Review limitations in the evidence and drug approval process,
  • Provide some examples of post-medication approval outcomes of some cancer drugs.
Vinay Prasad
Bite-sized Pearls from a Doctor With Little Patients: Pediatric Update 2017
  • Discuss the biggest practice change(s) in pediatrics in 2017,
  • Discuss any relevant vaccinations and their evidence that may warrant primary care promotion,
  • Discuss epidemiological concerns for the pediatric populations in Alberta.
Sam Wong
Social Determinants of Health: How a Warm Meal and Dry Home Beat 90% of Medications
  • Briefly define social determinants of health and explain how social factors are associated and determine many health outcomes,
  • Provide explicit examples of how social factors (income, housing) affect clinical outcomes,
  • Provide some initial ideas on how to help improve social determinants of health.
Tony Nickonchuk